Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy

Fig. 2

Change in the m-MBR before and after 1/2PDT and 1/3PDT in patients with chronic CSC. The change in the m-MBR was evaluated at baseline and 2 weeks, and 1, 3, and 6 months after 1/2PDT and 1/3PDT in patients with chronic CSC. The solid line represents the 1/2PDT group, and the dashed line represents the 1/3PDT group. The error bars represent the standard deviations of the participants. The asterisk represents significant differences between the 1/2PDT and 1/3PDT groups. * p < 0.05 (Steel test). 1/2PDT: half-dose verteporfin photodynamic therapy, 1/3PDT: one-third dose verteporfin photodynamic therapy, CSC: central serous chorioretinopathy, m-MBR: macular mean blur rate

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us